Baron K T, Thayer S A
Department of Pharmacology, University of Minnesota Medical School, Minneapolis 55455, USA.
Eur J Pharmacol. 1997 Dec 11;340(2-3):295-300. doi: 10.1016/s0014-2999(97)01433-7.
The effects of 7-chloro-3,5-dihydro-5-phenyl-1H-4,1-benzothiazepine-2-on (CGP37157), an inhibitor of mitochondrial Na+/Ca2+ exchange, on depolarization-induced intracellular free Ca2+ concentration ([Ca2+]i) transients were studied in cultured rat dorsal root ganglion neurons with indo-1-based microfluorimetry. A characteristic plateau in the recovery phase of the [Ca2+]i transient resulted from mitochondrion-mediated [Ca2+]i buffering. It was blocked by metabolic poisons and was not dependent on extracellular Ca2+. CGP37157 produced a concentration-dependent decrease in the amplitude of the mitochondrion-mediated plateau phase (IC50 = 4 +/- 1 microM). This decrease in [Ca2+]i was followed by an increase in [Ca2+]i upon removal of the drug, suggesting that Ca2+ trapped in the matrix was released when the CGP37157 was removed from the bath. CGP37157 also inhibited depolarization-induced Ca2+ influx at the concentrations required to see effects on [Ca2+]i buffering. Thus, CGP37157 inhibits mitochondrial Na+/Ca2+ exchange and directly inhibits voltage-gated Ca2+ channels, suggesting caution in its use to study [Ca2+]i regulation in intact cells.
采用基于indo-1的显微荧光测定法,在培养的大鼠背根神经节神经元中研究了线粒体Na+/Ca2+交换抑制剂7-氯-3,5-二氢-5-苯基-1H-4,1-苯并硫氮杂䓬-2-酮(CGP37157)对去极化诱导的细胞内游离Ca2+浓度([Ca2+]i)瞬变的影响。[Ca2+]i瞬变恢复阶段的特征性平台是由线粒体介导的[Ca2+]i缓冲作用导致的。它被代谢毒物阻断,且不依赖于细胞外Ca2+。CGP37157使线粒体介导的平台期幅度呈浓度依赖性降低(IC50 = 4±1 microM)。[Ca2+]i的这种降低在药物去除后接着出现[Ca2+]i升高,这表明当从浴液中去除CGP37157时,被困在基质中的Ca2+被释放。CGP37157在对[Ca2+]i缓冲产生影响所需的浓度下也抑制去极化诱导的Ca2+内流。因此,CGP37157抑制线粒体Na+/Ca2+交换并直接抑制电压门控Ca2+通道,这表明在完整细胞中使用它来研究[Ca2+]i调节时需谨慎。